Munafa Stock Market Course + Intraday & FNO calls 
RDY NEWS why is Dr. Reddy's Laboratories Ltd price falling or rising
RDY NEWS reasons for why stock price of Dr. Reddy's Laboratories Ltd is falling or rising
RDY Dr Reddy is falling or rising technical reasons
Technical analysis forecast of Dr Reddy Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Dr Reddy RDY at this time. Stock is rising and might rise more.
It appears as if Dr Reddy RDY gave a large move recently.
Stock of Dr Reddy (RDY) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Dr Reddy is bullish for shortterm, and stock might move up till 14.5 or till 14.8. Use a stoploss of 14.27 and if this stock hits its stoploss, then it can fall down till 14.02
RDY Dr Reddy is falling or rising NEWS fundamental reasons
Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say Dr Reddy's Laboratories is poised to launch its generic semaglutide injection, potentially named Obeda, in India by March. This move anticipates the March 2026 patent expiry for the active ingredient in Novo Nordisk's Ozempic and Wegovy. The Indian drugmak - NEWS as on 2026-02-25 indiatimes.com
Dr Reddy's readies day-1 launch of semaglutide generic Dr Reddy's Laboratories is set to launch a generic version of semaglutide in India on March 21. The company plans to offer both oral and injectable formats at competitive prices. This move aims to increase access to the popular weight-loss and diabetes mol - NEWS as on 2026-02-19 indiatimes.com
Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories closes at 1269.4 - NEWS as on 2026-02-18 indiatimes.com
Dr Reddy's says Wegovy copycat to be priced competitively, with 50-60% discounts feasible Indian drugmaker Dr Reddy's Laboratories is set to launch a generic version of the popular weight-loss drug Wegovy. The company aims to offer it at a price up to 60% lower than the original. This move comes as the patent for semaglutide, the active ingredi - NEWS as on 2026-02-17 indiatimes.com
More announcements and NEWS
RDY Dr. Reddy's Laboratories Ltd current price & indicator signals
Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 02 Mon Mar 2026 | 14.38 | 14.20 to 14.45 | 0% | 0.85 times |
| 27 Fri Feb 2026 | 14.38 | 14.24 to 14.41 | -1.37% | 0.69 times |
| 26 Thu Feb 2026 | 14.58 | 14.44 to 14.73 | -0.14% | 0.84 times |
| 25 Wed Feb 2026 | 14.60 | 14.53 to 14.80 | -1.22% | 1.05 times |
| 24 Tue Feb 2026 | 14.78 | 14.51 to 14.79 | 0.54% | 1.12 times |
| 23 Mon Feb 2026 | 14.70 | 14.53 to 14.75 | 1.45% | 1.06 times |
| 20 Fri Feb 2026 | 14.49 | 14.20 to 14.63 | 0.98% | 1.16 times |
| 19 Thu Feb 2026 | 14.35 | 14.21 to 14.53 | -0.49% | 1.12 times |
| 18 Wed Feb 2026 | 14.42 | 14.27 to 14.48 | 0.14% | 1.35 times |
| 17 Tue Feb 2026 | 14.40 | 14.23 to 14.43 | 1.84% | 0.76 times |
| 13 Fri Feb 2026 | 14.14 | 14.06 to 14.33 | 0% | 0.83 times |
| 13 Fri Feb 2026 | 14.14 | 14.06 to 14.33 | -1.19% | 0.83 times |
Videos related to: RDY NEWS why is Dr. Reddy's Laboratories Ltd price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
